NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/02/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Fundamento do pedido
Primeiro uso
Primeiro uso no comércio
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of a design reminiscent of a stylized lower case "a".
Titulares
Representantes
Ryan S. Hilbert HOLLEY & MENKER, PA
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medical diagnostic tests comprised of assays and reagents that test for the presence of medical biomarkers present in human blood and body fluids by applying advanced analytics; Medical diagnostic tests comprised of assays and reagents that test for the presence of medical biomarkers present in human blood and body fluids by applying machine learning technology; Diagnostic assays, reagents, and nucleotides for medical or clinical purposes
Classe 10
Blood collection kit comprised of blood collecting tubes; Blood testing apparatus; Diagnostic apparatus for medical purposes, namely, diagnostic kits consisting primarily of probes, buffers and reagents for use in liquid biopsy testing; Diagnostic tests comprising medical apparatus and instruments, namely, liquid biopsy testing systems; Medical diagnostic testing kits containing sterile medical specimen collection tools in the nature of lancets for the collection of blood for use in testing and for monitoring various medical conditions, and also including instructions and return shipping packaging; Testing kits containing medical laboratory research instruments for taking samples of human blood and body fluids for use in detecting cancer and other prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases
Classe 42
Providing medical research information regarding results of testing for various medical conditions; Providing scientific analysis and information regarding the results of laboratory testing in the field of various medical conditions; Laboratory testing services, namely, clinical processing of medical diagnostic testing kits; Medical research; Scientific research for medical purposes in the field of cancer and other prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases; Providing temporary use of non-downloadable software for use in creating, displaying, sharing and storing information, test results and data in the fields of cancer and other prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases; Providing online computer databases featuring medical research information in the fields of cancer and other prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases
Classe 44
Medical testing for diagnostic or treatment purposes; Medical diagnostic testing, monitoring, and reporting services; Consulting services in the fields of diagnostic medical testing; Providing medical information, consultancy and advisory services; Providing medical testing services and information in the fields of cancer and other prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases for diagnostic or treatment purposes; Medical testing services, namely, diagnostic testing services for detecting cancer and other prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases by identifying and analyzing biomarkers for diagnostic or treatment purposes; Providing screening, detection, and monitoring services for cancer and other prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/02/2026
REGISTERED-PRINCIPAL REGISTER
03/02/2026
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
14/01/2026
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
14/01/2026
STATEMENT OF USE PROCESSING COMPLETE
04/12/2025
USE AMENDMENT FILED
03/12/2025
TEAS STATEMENT OF USE RECEIVED
03/12/2025
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
30/10/2025
SOU EXTENSION 5 GRANTED
29/10/2025
CASE ASSIGNED TO INTENT TO USE PARALEGAL
29/10/2025
SOU TEAS EXTENSION RECEIVED
02/06/2025
SOU EXTENSION 5 FILED
01/06/2025
SOU EXTENSION 4 GRANTED
04/11/2024
SOU EXTENSION 4 FILED
04/11/2024
SOU TEAS EXTENSION RECEIVED
03/11/2024
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13/06/2024
SOU EXTENSION 3 GRANTED
05/06/2024
SOU EXTENSION 3 FILED
05/06/2024
SOU TEAS EXTENSION RECEIVED
05/06/2024
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/12/2023
SOU EXTENSION 2 GRANTED
02/12/2023
SOU EXTENSION 2 FILED
02/12/2023
SOU TEAS EXTENSION RECEIVED
02/12/2023
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/06/2023
SOU EXTENSION 1 GRANTED
05/06/2023
SOU EXTENSION 1 FILED
05/06/2023
SOU TEAS EXTENSION RECEIVED
05/06/2023
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/12/2022
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/10/2022
PUBLISHED FOR OPPOSITION
11/10/2022
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/09/2022
APPROVED FOR PUB - PRINCIPAL REGISTER
08/09/2022
TEAS/EMAIL CORRESPONDENCE ENTERED
02/09/2022
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/09/2022
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/09/2022
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/03/2022
NON-FINAL ACTION E-MAILED
02/03/2022
NON-FINAL ACTION WRITTEN
02/03/2022
ASSIGNED TO EXAMINER
22/02/2022
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/12/2021
NEW APPLICATION ENTERED
10/12/2021
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.